Analyst Viewpoint
Increase in demand for diagnostic imaging owing to aging population and surge in chronic disease burden are driving the global market. Medical cyclotron is used to produce radioisotopes for radiopharmaceuticals to diagnose and treat cancer. Rise in preference for SPECT and PET scans in hospitals and diagnostic centers for diagnosis of various cancers is another major factor propelling market expansion. Furthermore, surge in awareness about the efficient utilization of radiopharmaceuticals to treat cancer is expected to bolster the global medical cyclotron market size during the forecast period.
Technological advancements such as compact design and automation in medical cyclotrons offers lucrative opportunities to market players. Companies are focusing on developing affordable personalized medicine and targeted therapies for cancer treatment in order to increase market revenue.
The medical cyclotron market involves producing and distributing cyclotron systems used to generate radioisotopes for medical imaging and nuclear medicine. These systems speed up charged particles to create radioisotopes used in diagnoses and treatments.
Medical cyclotrons primarily produce short-lived radioisotopes for diagnostic imaging such as PET scans and manufacture isotopes used in targeted cancer therapies and radiopharmaceuticals.
Recent progress in cyclotron technology has led to more efficient systems. These updated cyclotrons aim to improve radionuclide production, broaden imaging capabilities, and enhance diagnostic precision. Manufacturers focus on innovations enabling higher radioisotope yields, shorter production times, and better radionuclide purity.
Efforts are ongoing to create compact, cost-effective cyclotrons suited for smaller healthcare facilities and research centers. Increase in emphasis on early disease detection, personalized medicine, and integrating advanced technologies such as PET-CT and SPECT with cyclotron-made radiopharmaceuticals is likely to fuel global medical cyclotron market growth in the near future.
SPECT and PET are modern systems used to detect and treat cancer, cardiovascular diseases, and other neurology related diseases. PET installations across the world have cyclotrons beside a PET machine. PET radioisotopes have relatively short half-lives. Once the radioactive isotope is produced, it has to be synthesized and injected into a patient as soon as possible.
According to the American Nuclear Society, 90% of radioisotopes are used in gamma cameras or PET scan nuclear diagnostics. Remaining 10% are used in radioactive therapeutics drugs to treat diseases such as cancer, heart diseases, gastrointestinal, endocrine, and neurological disorders.
Molecular imaging with novel radiopharmaceuticals has been engineered to target specific subcellular processes and improve diagnostic accuracy using radioactive molecule as a tracer. These factors are expected to bolster the global medical cyclotron market in the next few years.
Radionuclide therapy has emerged as a successful treatment method for persistent diseases, while exhibiting lower levels of toxic side effects. Thus, there has been a notable surge in the global production of radioisotopes, intended for utilization in both medical imaging and nuclear medicine applications.
The World Nuclear Association reports that radioisotopes find applications in medical practices across more than 10,000 hospitals worldwide. Around 90% of medical procedures, including diagnosis and treatment of conditions such as infectious diseases, cancer, and neurological disorders, rely on these radioisotopes.
Continuous rise in research and development activities, coupled with increase in pool of patients afflicted with ailments such as cancer, has triggered advancements in medical technology. This has led to the introduction of innovative, technologically advanced systems aimed at improving treatment outcomes. Consequently, the global medical cyclotron market is poised for significant growth in the next few years.
In terms of product, the cyclotron 16-24 MeV segment is projected to account for the largest global medical cyclotron market share during the forecast period. Compared to larger cyclotrons, 16-24 MeV models are smaller. This makes them more affordable for mid-sized hospitals and clinics seeking to expand their nuclear medicine capabilities. The 16-24 MeV cyclotrons are easy to use and have the ability to produce various radioisotopes for essential diagnostic procedures.
Based on application, the diagnosis segment is expected dominate the global medical cyclotron market demand during the forecast period. This is ascribed to versatility of cyclotrons in FDG production, theranostics, and personalized medicine which are used to diagnose various diseases. As healthcare technology evolves, cyclotrons are likely to continue to play a critical role in diagnosis and treatment of diseases.
However, applications of medical cyclotron are increasing at a rapid pace across the world. Their role in drug development, preclinical studies, radiopharmaceutical optimization, and translational medicine is becoming increasingly crucial. As research continues to propel advancements in medical imaging and therapy, cyclotrons are poised to play a significant role in shaping the future of healthcare.
In terms of end-user, the hospitals segment is anticipated to witness robust growth during forecast period. High demand for diagnostic imaging, the need for on-site radioisotope production, cost-effectiveness for high-volume hospitals, advancements in technology, and the versatility of cyclotrons are ascribed to the segment’s market dominance.
As healthcare continues to evolve, hospitals are likely to remain the primary users of medical cyclotrons, driving innovation and improving patient care through efficient and reliable access to this vital technology.
North America dominated the global market in 2022. This is ascribed to availability of advanced healthcare infrastructure, presence of prominent pharmaceutical & biotechnology firms, and substantial investment in research & development.
According to the Centers for Disease Control and Prevention (CDC), chronic diseases such as cancer, heart disease, and diabetes affect over 80% of American adults. This high prevalence fuels demand for diagnostic imaging tools such as PET scans that rely on cyclotrons for radioisotope production.
As per medical cyclotron market forecast, the industry in Europe is likely to expand at a high CAGR during the forecast period. Advancements in medical technologies play a significant role in identifying cancer and diabetes at early stages, leading to improved treatment outcomes. Early detection enables for more targeted and personalized therapies, enhancing patient response and survival rates.
The market in Asia Pacific is projected to grow at a rapid pace in the next few years. This is ascribed to rise in prevalence of diseases and increase in geriatric population, specifically in China India, and Japan. Moreover, lifestyle changes and environmental factors contribute to increased incidence of cancer and diabetes.
The global medical cyclotron market is fragmented, with the presence of several players. Key players have adopted strategies such as partnerships and merger & acquisition in order to increase market share.
GE Healthcare, IBA Radiopharma Solutions, Sumitomo Heavy Industries, Ltd., Advanced Cyclotron Systems, Siemens Healthineers AG, and Best Cyclotron Systems, Inc. are prominent players in the medical cyclotron market.
Key players in the medical cyclotron market report have been profiled based on parameters such as company overview, latest developments, business strategies, application portfolio, business segments, and financial overview.
| Attribute | Detail |
|---|---|
| Size in 2022 | US$ 221.3 Mn |
| Forecast Value in 2031 | More than US$ 306.3 Mn |
| Growth Rate (CAGR) | 4.6% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 221.3 Mn in 2022
It is projected to reach more than US$ 306.3 Mn by 2031
The CAGR is anticipated to be 4.6% from 2023 to 2031
North America is expected to account for the largest share from 2023 to 2031
GE Healthcare, IBA Radiopharma Solutions, Sumitomo Heavy Industries, Ltd., Advanced Cyclotron Systems, Siemens Healthineers AG, and Best Cyclotron Systems, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Cyclotron Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Cyclotron Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario
5.2. Overview of types of cyclotrons currently on the market for various applications
5.3. Technological Advancements
5.4. Cyclotron and Radiopharmaceutical Facilities per region
5.5. COVID-19 Impact Analysis
6. Global Medical Cyclotron Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Cyclotron 10-12 MeV
6.3.2. Cyclotron 16-24 MeV
6.3.3. Cyclotron 24 MeV & above
6.4. Market Attractiveness Analysis, by Product
7. Global Medical Cyclotron Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Diagnosis
7.3.1.1. Oncology
7.3.1.2. Cardiology
7.3.1.3. Neurology
7.3.2. Research
7.4. Market Attractiveness Analysis, by Application
8. Global Medical Cyclotron Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostics Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Medical Cyclotron Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Medical Cyclotron Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Cyclotron 10-12 MeV
10.2.2. Cyclotron 16-24 MeV
10.2.3. Cyclotron 24 MeV & above
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Diagnosis
10.3.1.1. Oncology
10.3.1.2. Cardiology
10.3.1.3. Neurology
10.3.2. Research
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Diagnostics Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Medical Cyclotron Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Cyclotron 10-12 MeV
11.2.2. Cyclotron 16-24 MeV
11.2.3. Cyclotron 24 MeV & above
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Diagnosis
11.3.1.1. Oncology
11.3.1.2. Cardiology
11.3.1.3. Neurology
11.3.2. Research
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Diagnostics Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Medical Cyclotron Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Cyclotron 10-12 MeV
12.2.2. Cyclotron 16-24 MeV
12.2.3. Cyclotron 24 MeV & above
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Diagnosis
12.3.1.1. Oncology
12.3.1.2. Cardiology
12.3.1.3. Neurology
12.3.2. Research
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Diagnostics Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of APAC
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Medical Cyclotron Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Cyclotron 10-12 MeV
13.2.2. Cyclotron 16-24 MeV
13.2.3. Cyclotron 24 MeV & above
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Diagnosis
13.3.1.1. Oncology
13.3.1.2. Cardiology
13.3.1.3. Neurology
13.3.2. Research
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Diagnostics Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Medical Cyclotron Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Cyclotron 10-12 MeV
14.2.2. Cyclotron 16-24 MeV
14.2.3. Cyclotron 24 MeV & above
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Diagnosis
14.3.1.1. Oncology
14.3.1.2. Cardiology
14.3.1.3. Neurology
14.3.2. Research
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Diagnostics Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. GE Healthcare
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. IBA Radiopharma Solutions
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Sumitomo Heavy Industries, Ltd.
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Advanced Cyclotron Systems
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Siemens Healthineers AG
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Best Cyclotron Systems, Inc.
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
List of Tables
Table 01: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 04: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 09: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 10: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 11: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 12: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 13: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 14: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 17: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 19: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 22: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 24: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 27: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 28: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 29: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 30: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 03: Global Medical Cyclotron Market Value Share Analysis, by Cyclotron 10-12 MeV, 2022 and 2031
Figure 04: Global Medical Cyclotron Market Value Share Analysis, by Cyclotron 16-24 MeV, 2022 and 2031
Figure 05: Global Medical Cyclotron Market Value Share Analysis, by Cyclotron 24 MeV above, 2022 and 2031
Figure 06: Global Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 07: Global Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 08: Global Medical Cyclotron Market Value Share Analysis, by Diagnosis, 2022 and 2031
Figure 09: Global Medical Cyclotron Market Value Share Analysis, by Research, 2022 and 2031
Figure 10: Global Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 11: Global Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 12: Global Medical Cyclotron Market Value Share Analysis, by Hospitals, 2022 and 2031
Figure 13: Global Medical Cyclotron Market Value Share Analysis, by Diagnostic Centers, 2022 and 2031
Figure 14: Global Medical Cyclotron Market Value Share Analysis, by Others, 2022 and 2031
Figure 15: Global Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 16: Global Medical Cyclotron Market Value Share Analysis, by Region, 2022 and 2031
Figure 17: Global Medical Cyclotron Market Attractiveness Analysis, by Region, 2023–2031
Figure 18: North America Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 19: North America Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 20: North America Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 21: North America Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 22: North America Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 23: North America Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: North America Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 25: North America Medical Cyclotron Market Value Share Analysis, by Country, 2022 and 2031
Figure 26: North America Medical Cyclotron Market Attractiveness Analysis, by Country, 2023–2031
Figure 27: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 28: Europe Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 29: Europe Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 30: Europe Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 31: Europe Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 32: Europe Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 33: Europe Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 34: Europe Medical Cyclotron Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 35: Europe Medical Cyclotron Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 36: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 37: Asia Pacific Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 38: Asia Pacific Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 39: Asia Pacific Medical Cyclotron Market Value Share Analysis, by Application 2022 and 2031
Figure 40: Asia Pacific Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 41: Asia Pacific Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 42: Asia Pacific Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 43: Asia Pacific Medical Cyclotron Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 44: Asia Pacific Medical Cyclotron Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 45: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 46: Latin America Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 47: Latin America Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 48: Latin America Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 49: Latin America Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 50: Latin America Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Latin America Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 52: Latin America Medical Cyclotron Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 53: Latin America Medical Cyclotron Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 54: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 55: Middle East & Africa Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 56: Middle East & Africa Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 57: Middle East & Africa Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 58: Middle East & Africa Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 59: Middle East & Africa Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Middle East & Africa Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 61: Middle East & Africa Medical Cyclotron Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 62: Middle East & Africa Medical Cyclotron Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 63: Global Medical Cyclotron Market Share Analysis, by Company, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Medical Cyclotron Market
